A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing “Precision Behavioral Management&rdquo

Autor: Blum K, Steinberg B, Gondre-Lewis MC, Baron D, Modestino EJ, Badgaiyan RD, Downs BW, Bagchi D, Brewer R, McLaughlin T, Bowirrat A, Gold M

Publikováno v: Psychology Research and Behavior Management, Vol Volume 14, Pp 2115-2134 (2021)

Kenneth Blum,1– 5 Bruce Steinberg,6 Marjorie C Gondre-Lewis,7 David Baron,1 Edward J Modestino,6 Rajendra D Badgaiyan,8– 10 B William Downs,11 Debasis Bagchi,11 Raymond Brewer,5 Thomas McLaughlin,12 Abdalla Bowirrat,13 Mark Gold14 1Center for Psy

Externí odkaz: https://doaj.org/article/309bdc42fb144e8fb8ffe17768c42763

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Editorial: Women in behavioral neuroscience: 2022.

Autor: Maeng LY; Department of Psychology, Developmental and Brain Sciences Program, University of Massachusetts Boston, Boston, MA, United States., Fattore L; CNR Institute of Neuroscience-Cagliari, National Research Council, Cagliari, Italy., Gondré-Lewis MC; Developmental NeuroPsychoPharmacology Laboratory, Department of Anatomy, Howard University College of Medicine, Washington, DC, United States.

Publikováno v: Frontiers in behavioral neuroscience [Front Behav Neurosci] 2024 Feb 07; Vol. 18, pp. 1374244. Date of Electronic Publication: 2024 Feb 07 (Print Publication: 2024).

Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?

Autor: Gondré-Lewis MC; Neuropsychopharmacology Laboratory, Department of Anatomy, Howard University College of Medicine, Washington, DC 20059, USA., Elman I; Department of Psychiatry, Cambridge Health Alliance/Harvard Medical School, Cambridge, MA 02139, USA., Alim T; Department of Psychiatry and Behavioral Sciences, Howard University College of Medicine, Washington, DC 20059, USA., Chapman E; Department of Psychiatry and Behavioral Sciences, Howard University College of Medicine, Washington, DC 20059, USA., Settles-Reaves B; Neuropsychopharmacology Laboratory, Department of Anatomy, Howard University College of Medicine, Washington, DC 20059, USA., Galvao C; Neuropsychopharmacology Laboratory, Department of Anatomy, Howard University College of Medicine, Washington, DC 20059, USA., Gold MS; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA., Baron D; Graduate College, Western University Health Sciences, Pomona, CA 91766, USA., Kazmi S; College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA., Gardner E; Neuropsychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Gupta A; Future Biologics, Lawrenceville, GA 30043, USA., Dennen C; The Kenneth Blum Behavioral & Neurogenetic Institute, Austin, TX 78701, USA., Blum K; Graduate College, Western University Health Sciences, Pomona, CA 91766, USA.; The Kenneth Blum Behavioral & Neurogenetic Institute, Austin, TX 78701, USA.; Department of Clinical Psychology and Addiction, Institute of Psychology, Faculty of Education and Psychology, ELTE Eötvös Loránd University, Egyetem tér 1-3, 1053 Budapest, Hungary.; Department of Psychiatry, School of Medicine, University of Vermont, Burlington, VT 05405, USA.; Centre for Genomics and Applied Gene Technology, Institute of Integrative Omics and Applied Biotechnology, Nonakuri, Purba Medinipur 721172, West Bengal, India.; Department of Psychiatry, Wright State University Boonshoft School of Medicine and Dayton VA Medical Centre, Dayton, OH 45324, USA.

Publikováno v: Biomedicines [Biomedicines] 2022 Apr 07; Vol. 10 (4). Date of Electronic Publication: 2022 Apr 07.

High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial.

Autor: Moran M; Pain Consultants of San Antonio, San Antonio, TX, USA.; Department of Nutrigenomics, Geneus Health, LLC, San Antonio, TX, USA., Blum K; Department of Nutrigenomics, Geneus Health, LLC, San Antonio, TX, USA. drd2gene@gmail.com.; Department of Psychiatry, University of Vermont, Burlington, VT, USA. drd2gene@gmail.com.; Division of Addiction Services, Dominion Diagnostics, North Kingston, RI, USA. drd2gene@gmail.com.; Western University Health Science Centers, Graduate College, Pompano, CA, USA. drd2gene@gmail.com.; Institute of Psychology, Eotvos Loránd University, Budapest, Hungary. drd2gene@gmail.com.; Department of Psychiatry, Wright University Boonshoft School of Medicine, Dayton, OH, USA. drd2gene@gmail.com.; The Kenneth Blum Behavioral and Neurogenetic Institute, (Division of Ivitalize Inc), Austin, TX, USA. drd2gene@gmail.com.; Division of Nutrigenomics, Victory Nutrition International, LLC, Lederoch, PA, USA. drd2gene@gmail.com.; Division of Clinical Neurology, Path Foundation NY, New York, NY, USA. drd2gene@gmail.com., Ponce JV; Department of Nutrigenomics, Geneus Health, LLC, San Antonio, TX, USA., Lott L; Department of Nutrigenomics, Geneus Health, LLC, San Antonio, TX, USA., Gondré-Lewis MC; Department of Anatomy, Developmental Neuro-Psycho-Pharmacology Laboratory, Howard University College of Medicine, Washington, DC, USA., Badgaiyan S; Department of Nutrigenomics, Geneus Health, LLC, San Antonio, TX, USA., Brewer R; Department of Nutrigenomics, Geneus Health, LLC, San Antonio, TX, USA.; The Kenneth Blum Behavioral and Neurogenetic Institute, (Division of Ivitalize Inc), Austin, TX, USA., Downs BW; Division of Nutrigenomics, Victory Nutrition International, LLC, Lederoch, PA, USA., Fynman P; Comprehensive Pain Management, Syosset, NY, USA., Weingarten A; Comprehensive Pain Management, Syosset, NY, USA.; Department of Psychiatry, New York Medical College, Valhalla, NY, USA., Cadet JL; Molecular Neuropsychiatry Branch, National Institutes of Health, Bethesda, MD, USA., Smith DE; Department of Pharmacology, College of Medicine, University of San Francisco, San Francisco, CA, USA., Baron D; Western University Health Science Centers, Graduate College, Pompano, CA, USA., Thanos PK; Department of Psychology & Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Research Institute on Addictions, University at Buffalo, Buffalo, NY, USA., Modestino EJ; Department of Psychology, Curry College, Milton, MA, USA., Badgaiyan RD; Department of Psychiatry, Icahn School of Medicine Mt Sinai, New York, NY, USA.; Department of Psychiatry, South Texas Veteran Health Care System, Audie L. Murphy Memorial VA Hospital, San Antonio, TX, USA.; Long School of Medicine, University of Texas Medical Center, San Antonio, TX, USA.; Center For Psychiatric Medicine, Lawrence, MA, USA.; Department of Psychiatry, Harvard School of Medicine, Boston, MA, USA., Elman I; Department of Psychiatry, Harvard University School of Medicine, Cambridge, MA, USA., Gold MS; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.

Publikováno v: Molecular neurobiology [Mol Neurobiol] 2021 Jul; Vol. 58 (7), pp. 3335-3346. Date of Electronic Publication: 2021 Mar 08.